Skip to main content

Table 1

From: TMPRSS2-ERG fusions confer efficacy of enzalutamide in an in vivo bone tumor growth model

CRPC Genes Forward (5′ ➔ 3′) Reverse (5′ ➔ 3′)
UBE2C TGGTCTGCCCTGTATGATGT AAAAGCTGTGGGGTTTTTCC
CDK1 CCTAGTACTGCAATTCGGGAAATT CCTGGAATCCTGCATAAGCAC
CCNA2 CAGAAAACCATTGGTCCCTC CACTCACTGGCTTTTCATCTTC
CDC20 CCTCTGGTCTCCCCATTAC ATGTGTGACCTTTGAGTTCAG
TMPRSS2 CAGGAGTGTACGGGAATGTGATGGT GATTAGCCGTCTGCCCTCATTTGT
GAPDH ATCACCATCTTCCAGGAGCGA GCCAGTGAGCTTCCCGTTCA